| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $6.1M | +22.1% | -15.9% |
| SG&A Expense | $2.4M | -0.2% | -25.7% |
| Operating Income | -$8.5M | -14.8% | +24.6% |
| Interest Expense | $850K | — | — |
| Pre-tax Income | -$9.2M | -51.8% | -195.0% |
| Income Tax | $3K | +50.0% | — |
| Net Income | -$9.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.9M | -50.7% | -70.6% |
| Current Assets | $8.9M | -46.7% | -68.7% |
| Total Assets | $26.2M | -31.2% | -56.4% |
| Current Liabilities | $5.2M | -16.5% | -41.6% |
| Stockholders' Equity | $10.5M | -45.3% | -72.3% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.0M | — | — |
| Capital Expenditures | $2K | — | — |
| Investing Cash Flow | $107K | — | — |
| Financing Cash Flow | $11.9M | — | — |
| Free Cash Flow | -$22.0M | — | — |
| -195.1% |
| EPS (Basic) | $0.29 | +52.6% | +193.5% |
| EPS (Diluted) | $0.29 | +52.6% | +193.5% |